158 related articles for article (PubMed ID: 15733060)
1. Vitronectin stabilizes thrombi and vessel occlusion but plays a dual role in platelet aggregation.
Reheman A; Gross P; Yang H; Chen P; Allen D; Leytin V; Freedman J; Ni H
J Thromb Haemost; 2005 May; 3(5):875-83. PubMed ID: 15733060
[TBL] [Abstract][Full Text] [Related]
2. Vitronectin inhibits the thrombotic response to arterial injury in mice.
Fay WP; Parker AC; Ansari MN; Zheng X; Ginsburg D
Blood; 1999 Mar; 93(6):1825-30. PubMed ID: 10068653
[TBL] [Abstract][Full Text] [Related]
3. Fibrin-incorporated vitronectin is involved in platelet adhesion and thrombus formation through homotypic interactions with platelet-associated vitronectin.
Wu YP; Bloemendal HJ; Voest EE; Logtenberg T; de Groot PG; Gebbink MF; de Boer HC
Blood; 2004 Aug; 104(4):1034-41. PubMed ID: 15069014
[TBL] [Abstract][Full Text] [Related]
4. Plasminogen activator inhibitor-1 and its cofactor vitronectin stabilize arterial thrombi after vascular injury in mice.
Konstantinides S; Schäfer K; Thinnes T; Loskutoff DJ
Circulation; 2001 Jan; 103(4):576-83. PubMed ID: 11157725
[TBL] [Abstract][Full Text] [Related]
5. Anfibatide, a novel GPIb complex antagonist, inhibits platelet adhesion and thrombus formation in vitro and in vivo in murine models of thrombosis.
Lei X; Reheman A; Hou Y; Zhou H; Wang Y; Marshall AH; Liang C; Dai X; Li BX; Vanhoorelbeke K; Ni H
Thromb Haemost; 2014 Feb; 111(2):279-89. PubMed ID: 24172860
[TBL] [Abstract][Full Text] [Related]
6. Thrombotic phenotype of mice with a combined deficiency in plasminogen activator inhibitor 1 and vitronectin.
Koschnick S; Konstantinides S; Schäfer K; Crain K; Loskutoff DJ
J Thromb Haemost; 2005 Oct; 3(10):2290-5. PubMed ID: 16194205
[TBL] [Abstract][Full Text] [Related]
7. Vimentin exposed on activated platelets and platelet microparticles localizes vitronectin and plasminogen activator inhibitor complexes on their surface.
Podor TJ; Singh D; Chindemi P; Foulon DM; McKelvie R; Weitz JI; Austin R; Boudreau G; Davies R
J Biol Chem; 2002 Mar; 277(9):7529-39. PubMed ID: 11744725
[TBL] [Abstract][Full Text] [Related]
8. Fibrinogen and von Willebrand factor-independent platelet aggregation in vitro and in vivo.
Yang H; Reheman A; Chen P; Zhu G; Hynes RO; Freedman J; Wagner DD; Ni H
J Thromb Haemost; 2006 Oct; 4(10):2230-7. PubMed ID: 16824188
[TBL] [Abstract][Full Text] [Related]
9. Plasminogen activator inhibitor-1 and vitronectin promote vascular thrombosis in mice.
Eitzman DT; Westrick RJ; Nabel EG; Ginsburg D
Blood; 2000 Jan; 95(2):577-80. PubMed ID: 10627465
[TBL] [Abstract][Full Text] [Related]
10. Receptor-interacting protein kinase 3 promotes platelet activation and thrombosis.
Zhang Y; Zhang J; Yan R; Tian J; Zhang Y; Zhang J; Chen M; Cui Q; Zhao L; Hu R; Jiang M; Li Z; Ruan C; He S; Dai K
Proc Natl Acad Sci U S A; 2017 Mar; 114(11):2964-2969. PubMed ID: 28242694
[TBL] [Abstract][Full Text] [Related]
11. Vitronectin binds to activated human platelets and plays a role in platelet aggregation.
Asch E; Podack E
J Clin Invest; 1990 May; 85(5):1372-8. PubMed ID: 1692034
[TBL] [Abstract][Full Text] [Related]
12. Epithelial (E)-Cadherin is a Novel Mediator of Platelet Aggregation and Clot Stability.
Scanlon VM; Teixeira AM; Tyagi T; Zou S; Zhang PX; Booth CJ; Kowalska MA; Bao J; Hwa J; Hayes V; Marks MS; Poncz M; Krause DS
Thromb Haemost; 2019 May; 119(5):744-757. PubMed ID: 30861547
[TBL] [Abstract][Full Text] [Related]
13. Reduced nicotinamide adenine dinucleotide phosphate inhibits rat platelet aggregation and p38 phosphorylation.
Gu Y; Sheng R; Wu J; Zhou Y; Qin ZH
Thromb Res; 2018 Nov; 171():121-129. PubMed ID: 30292134
[TBL] [Abstract][Full Text] [Related]
14. Plasma fibronectin depletion enhances platelet aggregation and thrombus formation in mice lacking fibrinogen and von Willebrand factor.
Reheman A; Yang H; Zhu G; Jin W; He F; Spring CM; Bai X; Gross PL; Freedman J; Ni H
Blood; 2009 Feb; 113(8):1809-17. PubMed ID: 19036705
[TBL] [Abstract][Full Text] [Related]
15. Neferine exerts its antithrombotic effect by inhibiting platelet aggregation and promoting dissociation of platelet aggregates.
Zhou YJ; Xiang JZ; Yuan H; Liu H; Tang Q; Hao HZ; Yin Z; Wang J; Ming ZY
Thromb Res; 2013 Aug; 132(2):202-10. PubMed ID: 23773522
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of platelet adhesion and aggregation by a defined region (Gly-486-Lys-502) of high molecular weight kininogen.
Chavakis T; Boeckel N; Santoso S; Voss R; Isordia-Salas I; Pixley RA; Morgenstern E; Colman RW; Preissner KT
J Biol Chem; 2002 Jun; 277(26):23157-64. PubMed ID: 11970955
[TBL] [Abstract][Full Text] [Related]
17. Thrombus growth and embolism on tissue factor-bearing collagen surfaces under flow: role of thrombin with and without fibrin.
Colace TV; Muthard RW; Diamond SL
Arterioscler Thromb Vasc Biol; 2012 Jun; 32(6):1466-76. PubMed ID: 22516070
[TBL] [Abstract][Full Text] [Related]
18. Hierarchical organization of the hemostatic response to penetrating injuries in the mouse macrovasculature.
Welsh JD; Poventud-Fuentes I; Sampietro S; Diamond SL; Stalker TJ; Brass LF
J Thromb Haemost; 2017 Mar; 15(3):526-537. PubMed ID: 27992950
[TBL] [Abstract][Full Text] [Related]
19. Epidermal growth factor-like repeats of SCUBE1 derived from platelets are critical for thrombus formation.
Liao WJ; Wu MY; Peng CC; Tung YC; Yang RB
Cardiovasc Res; 2020 Jan; 116(1):193-201. PubMed ID: 30722019
[TBL] [Abstract][Full Text] [Related]
20. First Selective 12-LOX Inhibitor, ML355, Impairs Thrombus Formation and Vessel Occlusion In Vivo With Minimal Effects on Hemostasis.
Adili R; Tourdot BE; Mast K; Yeung J; Freedman JC; Green A; Luci DK; Jadhav A; Simeonov A; Maloney DJ; Holman TR; Holinstat M
Arterioscler Thromb Vasc Biol; 2017 Oct; 37(10):1828-1839. PubMed ID: 28775075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
